News & Events

News &
Events

Tarsier Pharma Announces Presentation at the 27th Annual AUS Winter Symposium

January 10, 2024

Tarsier Pharma Announces Presentation at the 27th Annual AUS Winter Symposium

Tarsier Pharma, Ltd, will attend the 27th Annual American Uveitis Society (AUS) Winter Symposium, taking place in Park City, UT on January 13-15, 2024.

Phase III data from the recent TRS4Vision trial will be presented by Dr. Lana Rifkin.

AUS Winter 2024 Presentation Details:
Presentation Title: Phase III Trial Highlights Potential of TRS01, as a Novel Non-Steroid Treatment for Active Noninfectious Anterior Uveitis in Uveitic Glaucoma
Date: Monday, January 15, 2024
Time: 07:56 to 08:07am
Location: Westgate Park City

 

About Tarsier Pharma

Tarsier Pharma is a clinical stage biopharmaceutical company, focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat immune-mediated blinding diseases in the front and back of the eye.

 

Contact:

Investor Relations Tarsier Pharma

[email protected]

Scroll to Top